March 2026
The global hospital infection therapeutics market size is projected to hit around USD 17.05 billion by 2035 from USD 12.82 billion in 2025 with a CAGR of 2.89%.
September 2026
The hospital acquired infection control market reached USD 23.79 billion in 2026, featuring leading hospital acquired infection control market companies such as 3M, STERIS, Ecolab, Getinge.
September 2026
The global parkinsons disease therapeutics market size is estimated at USD 7.49 billion in 2026 and is projected to hit around USD 14.28 billion by 2035 with a CAGR of 7.36%.
September 2026
The sepsis therapeutics market size was valued at USD 4,27 billion in 2026 and is expected to Attain around USD 7.36 billion by 2034 with a CAGR of 7.06%.
September 2026
The pain management therapeutics market size accounted for USD 91.54 billion in 2026 and is predicted to hit around USD 127.78 billion by 2035, with a CAGR of 3.78%.
September 2026
The infection control market size was exhibited at USD 283.47 billion in 2026 and is projected to hit around USD 500.82 billion by 2035, growing at a CAGR of 6.55%.
September 2026
The anti-inflammatory therapeutics market size was estimated at USD 113.58 billion in 2026 and is expected to hit USD 164.44 billion by 2035, with a CAGR of 4.14%.
September 2026
The global amyloidosis therapeutics market size was valued at USD 3.44 billion in 2026 and is expected to hit around 6.92 billion by 2035, growing at a CAGR of 8.09% from 2026 to 2035.
September 2026
The mRNA vaccines and therapeutics market size reached USD 130.20Â billion in 2026 and is projected to surpass around USD 297.84 billion by 2035 with a CAGR of 9.81%.
September 2026
The global esophageal cancer therapeutics market size was evaluated at USD 3.51 billion in 2026 and is predicted to hit around USD 7.75 billion by 2035, growing at a CAGR of 9.22%.
September 2026
The lung cancer therapeutics market size totalled USD 38.23 billion in 2026, with major lung cancer therapeutics market players including AstraZeneca, BoehringerIngelheim, Bristol-Myers Squibb Company, Eli Lilly and Company, Hoffmann-La Roche, Merck & Co, Pfizer Inc.
September 2026
The microbiome therapeutics market size reached USD 334.16 million in 2026, with leading microbiome therapeutics market companies including Seres Therapeutics, Nestlé Health Science, Finch Therapeutics.
September 2026
The global bacterial therapeutics market is growing as microbiome-based treatments gain traction in healthcare and biotechnology.
September 2026
The homecare diagnostics & therapeutics market size accounted for USD 291.51 billion in 2026 and is expected to hit USD 577.56 billion by 2035, with a CAGR of 7.90%.
September 2026
The global cancer therapeutics market size was evaluated at USD 232.14 billion in 2026 and is expected to surpass around USD 501.07 billion by 2035 with a CAGR of 8.95%.
September 2026
The U.S. hospital emergency department market is estimated to hit around USD 307.63 billion by 2035 increasing from USD 190.70 billion in 2026, with a CAGR of 5.44%.
September 2026
The pruritus therapeutics market size stood at USD 12.26 billion in 2026, with major pruritus therapeutics market companies including Bristol-Myers Squibb, Novartis AGÂ , Pfizer Inc.,Teva Pharmaceuticals.
September 2026
The infectious disease therapeutics market size is calculated at USD 37.67 billion in 2026 and is expected to hit around USD 53.48 billion by 2035 at a CAGR of 3.97%.
September 2026
The mRNA therapeutics market size was valued at USD 22.30 billion in 2026 and is expected to hit around USD 45.40 billion by 2035, growing at a CAGR of 8.1%.
September 2026
The global scleroderma therapeutics market size is projected to surpass around USD 4.48 billion by 2035 increasing from USD 2.88 billion in 2026, with a CAGR of 5.04%.
September 2026
The global small interfering RNA (siRNA) therapeutics market size is estimated to hit around USD 528.78 billion by 2035 increasing from USD 214.41 billion in 2026, with a CAGR of 10.55%.
September 2026
The global middle ear infections treatment market size is estimated to hit around USD 8.44 billion by 2035 increasing from USD 5.66 billion in 2026, with a CAGR of 4.55%.
September 2026
The global melanoma therapeutics market size accounted for USD 8.16 billion in 2026 and is expected to hit around USD 19.61 billion by 2035, at a CAGR of 10.25%.
September 2026
The global targeted therapeutics market size was estimated at USD 91.76 billion in 2026 and is projected to hit around USD 163.91 billion by 2035 with a CAGR of 6.69%.
September 2026
The global smart hospitals market size is accounted at USD 80.60 billion in 2026 and is projected to hit USD 337.04 billion by 2035, growing at a CAGR of 17.28%.
September 2026
The global non-Hodgkin's lymphoma therapeutics market size is estimated to hit around USD 20.94 billion by 2034, increasing from USD 11.80 billion in 2026, with a CAGR of 7.43%.
September 2026
The global narcolepsy therapeutics market size is accounted at USD 4.46 billion in 2026 and is expected to hit around USD 9.31 billion by 2035 with a CAGR of 8.49%.
September 2026
The U.S. acute hospital care market size is expected to attain around USD 2.57 trillion by 2035 from USD 1.45 trillion in 2026 with a notable CAGR of 6.65%.
September 2026
The global women's health therapeutics market size is predicted to hit around USD 66.62 billion by 2034 from USD 48.57 billion in 2026, with a CAGR of 4.03%.
September 2026
The hospital outsourcing market was valued at USD 473.64 billion in 2026 and is predicted to reach USD 1,192.54 billion by 2035 at a CAGR of 10.82% from 2026 to 2035.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com